All News Sandoz Group AG

Equities

SDZ

CH1243598427

Real-time Estimate Cboe Europe Other stock markets 11:13:22 2024-07-09 am EDT			5-day change	1st Jan Change
33.98 ^CHF	+0.24%		+4.86%	+25.91%

03:13pm	Mixed feelings
Jul. 08	Sandoz collaboration extension helps Evotec back to May high	DP

All News

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Evotec SE - Just - Evotec Biologics expands tech partnership for biosimilars with Sandoz	09:48am	AQ
Mixed feelings	09:13am
Sandoz collaboration extension helps Evotec back to May high	Jul. 08	DP
Sandoz: strategic partnership extended with Just - Evotec	Jul. 08	CF
Evotec's Biologics Segment Expands Sandoz Partnership	Jul. 08	MT
Swiss Market Index Edges Up Ahead of Key Inflation, Economic Data	Jul. 01	MT
New semester, new state of mind	Jul. 01
Sandoz: Pyzchiva approved in the United States	Jul. 01	CF
Sandoz Plans US Commercialization of Biosimilar for Psoriatic Disease Treatment After FDA Nod	Jul. 01	MT
FDA approves biosimilar Pyzchiva® (ustekinumab-ttwe), to be commercialized by Sandoz in US	Jul. 01	GL
Brussels Court Of Appeal Prohibits The Rebranding Of A Generic Pharmaceutical Into The Originator Reference Product In The Framework Of Parallel Import	Jun. 25	AQ
Sandoz AG Re-Submits the Biosimilar Drug EG12014 (Trastuzumab Biosimilar) 150 Mg Powder BLA to the US FDA	Jun. 13	CI
Amgen Files BPCIA Complaint Against Celltrion Regarding Denosumab	Jun. 10	AQ
European Biosimilar Regulatory Update	Jun. 10	AQ
AbbVie's tight grip on Humira market raises concerns about biosimilars	Jun. 07	RE
Improving access for patients: launch of Lisdexamfetamine further broadens Sandoz Canada portfolio	Jun. 05	AQ
Fresenius Kabi Announces FDA Acceptance Of ABLA For Prolia® / Xgeva® (Denosumab) Biosimilar Candidate FKS518	May. 31	AQ
Sandoz receives European Commission approval for Wyost and Jubbonti, the first and only biosimilars of denosumab in Europe	May. 23	AQ
European Commission grants first-of-a-kind biosimilar approval	May. 22	AQ
Sandoz: Marketing authorization for Wyost and Jubbonti in the EU	May. 22	CF

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Sandoz: Ready to unleash its full potential on its own

June 26, 2024 at 12:28 pm EDT

SANDOZ : Sandoz’s improvements are worth betting on

May 08, 2024 at 08:08 am EDT